Yuani Siegfried

PHD Doctor of Philosophy,  Mayo Clinic - Rochester 

Location: Africa

Consulting Services

Career Advice and Mentoring Biostatistics

Areas Of Interest

Calcium and Phospholipid Binding Protein p68 Doping in Sports Disease, Bronchial Family Reconstitution Syndromes, Collodion Baby D2E7 Antibody Syndromes, Cri-du-Chat Innate Behaviors Curiosity Lot Quality Assurance Sampling Institutional Management Team Lateral Pulvinar Nucleus Bronchospasm, Exercise-Induced Ventilation, Total Liquid Electroacoustic Impedance Test Cancer Pain Rainbow Trout Lhermitte Duclos Disease Occupational Therapy Dahl Salt Resistant Rats cAMP Dependent Protein Kinase Amoxicillin Anhydrous Tonic-Clonic Seizures, Generalised Commuting Minnesota Particulate Matter, Ultrafine LY139381 Curare-Like Agents Adenomas, Eosinophilic Otx2 Transcription Factor Thalamic Nucleus, Parafascicular Dacryocystostomy Salamanders

Professional Narrative

Dr. Yuani Siegfried was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Siegfried has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Medical Writer, Harvard Med 2009
Assistant Professor, Amgen 2009

Education

Master of Science in physician assistant, Baylor College 1996
Bachelor of science in nursing, Baylor College 2018

Referees


Publications

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Yin X, Mead BE, Safaee H, Langer R, Karp JM, Levy O. Engineering Stem Cell Organoids. Cell Stem Cell. 2016 Jan 7;18(1):25-38. doi: 10.1016/j.stem.2015.12.005. PMID: 26748754; PMCID: PMC4728053.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :